(PharmaNewsWire.Com, October 16, 2019 ) The global Advanced Visualization market is segmented on the basis of product, services, solution, imaging modality, clinical application and region. The factors driving market growth include technological advancements in AV software such as integration of PACS & AV tools, improved diagnostic interpretation with AV tools, rising prevalence of target diseases, and growing demand for advanced diagnostic procedures.
On the basis of products and services, the advanced visualization market is classified into hardware & software and services. In 2016, the hardware and software segment is estimated to account for the largest share of the market owing to factors such as the development of technologically advanced software, rising adoption of AV solutions in hospitals and imaging centers, and rising focus of healthcare organizations to streamline and increase workflow efficiency.
On the basis of type of solution, the market is segmented into enterprise-wide thin client-based solutions and stand-alone workstation-based solutions. In 2016, the enterprise-wide thin client-based solutions is expected to account for the largest share of the market due to offered benefits such as enhanced data storage capacity, data transfer capabilities, multi-user interface, streamlined analysis, and centralized post-processing solutions.
On the basis of clinical application, the market is segmented into radiology/interventional radiology, cardiology, orthopedics, oncology, vascular, neurology, and other clinical areas (obstetrics/gynaecology, urology, pulmonary, and gastroenterology).
On the basis of region, the advanced visualization market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). In 2016, North America is expected to account for the largest share of the market. Dominant position of North America in advanced visualization industry is attributed to the faster adoption of novel diagnostic imaging technologies (as compared to other regions), advancements in the field of advanced visualization technologies, large number of disease diagnostic procedures, and higher preference for advanced visualization solutions for diagnostic imaging.
As of 2015, the global advanced visualization market was dominated by General Electric Company (U.S.), Siemens AG (Germany), Koninklijke Philips N.V. (Netherlands), Toshiba Corporation (Japan), Terarecon, Inc. (U.S.), Fujifilm Holdings Corporation (Japan), Pro Medicus Limited (Australia), Carestream Health, Inc. (U.S.), Agfa-Geveart N.V. (Belgium), and Qi Imaging, LLC (U.S.), among others.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
